Last reviewed 2026-04-20 · How we verify

Oral low dose steroid

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Anaemia
• Neutropenia
• Hypertension
• Fatigue
• DIARRHOEA
• Constipation
• ANAEMIA
• Thrombocytopenia
• CONSTIPATION
• Infections and infestations - Other, specify
• OEDEMA PERIPHERAL
• Neutrophil count decreased

Key clinical trials

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) (PHASE3)
• SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
• Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment (NA)
• Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment (PHASE2, PHASE3)
• Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia (PHASE4)
• DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment (PHASE2)
• The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo. (PHASE4)
• A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Oral low dose steroid CI brief — competitive landscape report
• Oral low dose steroid updates RSS · CI watch RSS
• Manimarane Arjunan, MD,DM (Cardiology) portfolio CI